AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 19 filers reported holding AN2 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,148,525 | +89.2% | 1,563,963 | 0.0% | 0.68% | +82.7% |
| Q2 2023 | $13,293,686 | -13.9% | 1,563,963 | 0.0% | 0.37% | -34.2% |
| Q1 2023 | $15,436,315 | +3.6% | 1,563,963 | 0.0% | 0.56% | -10.3% |
| Q4 2022 | $14,904,567 | -47.0% | 1,563,963 | -3.3% | 0.63% | -45.8% |
| Q3 2022 | $28,098,000 | +124.3% | 1,616,665 | 0.0% | 1.16% | +91.9% |
| Q2 2022 | $12,529,000 | -48.6% | 1,616,665 | 0.0% | 0.60% | -37.9% |
| Q1 2022 | $24,363,000 | – | 1,616,665 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 433,330 | $6,530,000 | 1.89% |
| RA Capital Management | 3,666,663 | $55,257,000 | 1.21% |
| BVF INC/IL | 1,616,665 | $24,363,000 | 0.98% |
| Avidity Partners Management LP | 688,330 | $10,373,000 | 0.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 584,136 | $8,803,000 | 0.20% |
| COWEN AND COMPANY, LLC | 60,278 | $908,000 | 0.09% |
| Woodline Partners LP | 150,000 | $2,261,000 | 0.04% |
| Alyeska Investment Group, L.P. | 125,000 | $1,884,000 | 0.02% |
| Citadel Advisors | 1,419,851 | $20,593,000 | 0.00% |
| Anson Funds Management LP | 2,500 | $38,000 | 0.00% |